AstraZeneca’s Truqap Becomes First Targeted Therapy Approved for PTEN-Deficient Prostate Cancer
CAMBRIDGE, United Kingdom, June 12, 2026 AstraZeneca has secured a major regulatory milestone with the U.S. Food and Drug...
cancer therapy
Advertisement
Immunome Doses First Patient in Phase 1 Trial of IM-1617
BOTHELL, Wash., June 11, 2026 Immunome, Inc. announced the first patient has been dosed in a Phase 1 first-in-human...
Sanofi Wins EU Approval for Sarclisa SC in Multiple Myeloma
PARIS, France, June 8, 2026 Sanofi announced that the European Commission has approved Sarclisa® (isatuximab) subcutaneous (SC) for the...
Alligator Reports Global Phase 3 Progress for HLX22
LUND, Sweden, June 8, 2026 Alligator Bioscience announced a significant development in the ongoing global Phase 3 clinical trial...
Stelexis BioSciences Reports Breakthrough Phase 1 Eganelisib Results in AML and MDS
WALTHAM, Massachusetts, USA, June 2, 202 Stelexis BioSciences has announced encouraging Phase 1 clinical trial results for eganelisib, its...
Advertisements
Celcuity’s Gedatolisib Doubles Progression-Free Survival in Phase 3 Breast Cancer Trial
MINNEAPOLIS, Minnesota, USA , June 2, 2026 Celcuity has announced groundbreaking results from the Phase 3 VIKTORIA-1 clinical trial,...
Karyopharm Highlights Phase 3 SENTRY Trial Progress in Myelofibrosis
NEWTON, Mass., June 1, 2026 Karyopharm Therapeutics has announced that it will host an investor conference call featuring leading...
Rallybio and Avenzo Merge to Advance Oncology Pipeline with $215M Financing
NEW HAVEN, Conn. & SAN DIEGO, Calif., June 2, 2026 Rallybio Corporation and Avenzo Therapeutics announced a definitive merger...
Citius Oncology Reports Promising LYMPHIR Cancer Data
CRANFORD, N.J., June 1, 2026 Citius Oncology has announced encouraging Phase 1 clinical findings evaluating LYMPHIR® (denileukin diftitox-cxdl) in...
Servier’s Emi-Le Shows Promise in Rare ACC Cancer Trial
BOSTON, June 1, 2026 Servier has announced encouraging new clinical findings for Emiltatug Ledadotin (Emi-Le), an investigational B7-H4-targeted antibody-drug...
Advertisement
